Bandyopadhyay Susanta, Sutor Bernd, Hablitz John J
Dept. of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J Neurophysiol. 2006 Mar;95(3):1908-16. doi: 10.1152/jn.00881.2005. Epub 2005 Dec 7.
Application of 4-aminopyridine (4-AP) along with EAA) receptor antagonists produces gamma-aminobutyric acid (GABAA) receptor-dependent synchronized activity in interneurons. This results in waves of activity propagating through upper cortical layers. Because interneurons in the neocortex are excited by nicotinic acetylcholine receptor (nAChR) agonists, ACh may influence synchronization of these local neocortical interneuronal networks. To study this possibility, we have used voltage-sensitive dye imaging using the fluorescent dye RH 414 (30 microM) in rat neocortical slices. Recordings were obtained in the presence of 4-AP (100 microM) and the EAA receptor antagonists D-2-amino-5-phosphonvaleric acid (20 microM) and 6-cyano-7-nitro-quinoxaline-2,3-dione (10 microM). In response to intracortical stimulation, localized or propagated activity restricted to upper cortical layers was seen. Bath application of the ACh esterase inhibitor neostigmine (10 microM) and the nAChR agonist 1,1-dimethyl-4-phenyl-piperazinium iodide (DMPP; 10 microM) increased the response amplitude, the extent of spread, and the duration of this activity. These changes were seen in 13 of 16 slices tested with neostigmine (10 microM) and 4 of 7 slices tested with DMPP (10 microM). Application of the muscarinic AChR antagonist atropine (1 microM) did not block the enhancement of activity by neostigmine (n = 7). Application of dihydro-beta-erythroidine (10 microM), known, at this concentration, to selectively antagonize alpha4beta2-like nAChRs, blocked the effect of neostigmine (n = 5). The selective alpha7-like nAChR antagonist methyllycaconitine (50 nM) was ineffective (n = 5). These results suggest that activation of alpha4beta2-like nAChRs by endogenously released ACh can enhance synchronized activity in local neocortical inhibitory networks.
4-氨基吡啶(4-AP)与兴奋性氨基酸(EAA)受体拮抗剂联合应用可在中间神经元中产生γ-氨基丁酸(GABAA)受体依赖性同步活动。这导致活动波通过皮质上层传播。由于新皮质中的中间神经元受到烟碱型乙酰胆碱受体(nAChR)激动剂的兴奋,乙酰胆碱(ACh)可能会影响这些局部新皮质中间神经元网络的同步性。为了研究这种可能性,我们在大鼠新皮质切片中使用了电压敏感染料成像,使用荧光染料RH 414(30微摩尔)。在存在4-AP(100微摩尔)以及EAA受体拮抗剂D-2-氨基-5-磷酸戊酸(20微摩尔)和6-氰基-7-硝基喹喔啉-2,3-二酮(10微摩尔)的情况下进行记录。响应皮质内刺激,可见局限于皮质上层的局部或传播性活动。浴用乙酰胆碱酯酶抑制剂新斯的明(10微摩尔)和nAChR激动剂1,1-二甲基-4-苯基哌嗪碘化物(DMPP;10微摩尔)可增加该活动的反应幅度、传播范围和持续时间。在用新斯的明(10微摩尔)测试的16个切片中有13个出现了这些变化,在用DMPP(10微摩尔)测试的7个切片中有4个出现了这些变化。应用毒蕈碱型乙酰胆碱受体拮抗剂阿托品(1微摩尔)并未阻断新斯的明对活动的增强作用(n = 7)。应用二氢-β-刺桐啶(10微摩尔),已知在此浓度下可选择性拮抗α4β2样nAChR,可阻断新斯的明的作用(n = 5)。选择性α7样nAChR拮抗剂甲基lycaconitine(50纳摩尔)无效(n = 5)。这些结果表明,内源性释放的乙酰胆碱激活α4β2样nAChR可增强局部新皮质抑制性网络中的同步活动。